RE: IM Presentation7 Apr 2023 10:54
What i gleaned,
1 was really good for him to apologise for the missed revenues even thought it was out of his control
2 he clearly respected his shareholders and that he was very clear , personable and friendly in his answers
3 he was very clear and almost perplexed that someone would ask about finances and he was very clear we were funded forbthe foreseeable as per previous updates
4 he would not take a pay rise until PYC are profitable or generating significant revenue
5 the blood test collaboration was NOT the quarterly update, the trading update was and he explained why it was a week late but will make are it doesn't happen again
6 the project optimus presentation was a real coup for PYC and the listeners were mainly USA companies AND prospective clients
7 the upcoming conference is a real showcase for PYC and we have been given a huge stage to ahow what we can do in front of senior oncology clients
8 we might still hit the £1mln target for June but BOD took the Conservative decision to be prudent with the trading update
9 the 25 project pipeline has a range of scope and size but said average size of contracts range from £50k upwards , that equates to £1.25mln potentially (some contracts can be alot higher than the average size) He obviously couldn't say too much more
10 PYC are well respected in their field of oncology and their move.into personalised oncology will open up a very large opportunity
11 VAL 201 was a deal struck by the previous Ceo but confirmed it will still trigger a milestone payment for PYC
12 he is in talks with DoseMeRx and further updates will be coming
Sign In
Follow the stocks
